#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

novinkyvnemocnici

Rapid Strengthening and Long-term Stabilization – New Strategy for Sequential Treatment of Severe Osteoporosis

27. 9. 2023 Source: Osteoporosis – Trends in Sequential Therapy

Osteoanabolics have long been considered a treatment modality for osteoporosis that is only considered when antiresorptive medication lacks the desired efficacy. However, their role has been shifting in recent years based on new findings from clinical research, as evidenced by the conclusions of the expert working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (ESCEO), whose brief summary we bring.

amgenosteoporoza

Inhibition of Sclerostin in Osteoporosis Therapy

Romosozumab, a subcutaneously administered antibody against sclerostin, is one of the most potent…
27. 9. 2023 Source: Osteoporosis – Trends in Sequential Therapy
Gabrhelík

Doc. Tomáš Gabrhelík: Pain treatment should be seriously addressed by all fields, especially in seniors

Chronic pain is often underestimated, especially in older and polymorbid patients. On the other…
27. 9. 2023 Source: Analgesia
léčebné konopí extrakt

Three times on the topic of therapeutic cannabis usage possibilities – case studies from Czech practice

The following case studies from real Czech practice describe three cases of patients with various…
27. 9. 2023 Source: Medical Cannabis
roztroušená skleroza 22

Ocrelizumab in the treatment of multiple sclerosis in real-world practice – a systematic review of published studies

In controlled study programs, ocrelizumab has demonstrated beneficial effects on improving clinical…
27. 9. 2023 Source: Neurology - Multiple Sclerosis
krytí Zetuvit Plus Silicone Border

Innovation in Wound Healing: Zetuvit Plus Silicone Border for Optimal Wound Exudate Management

Excessive wound exudate can lead to delayed healing, skin damage around the wound, or leakage under…
26. 9. 2023 Source: Wound Healing
ulcerative colitis

Current Data of Tofacitinib in the Treatment of IBD: What Improvements in Endoscopic and Histologic Outcomes Can Be Achieved?

The oral Janus kinase inhibitor (JAKi) tofacitinib is currently approved for the treatment of…
20. 9. 2023 Source: Intestinal Inflammations
congres

Current News from ECCO 2023: Tofacitinib in the Treatment of Ulcerative Colitis in Real-World Practice

At the 18th ECCO Congress, held in March 2023 in Copenhagen, results from a Spanish real-world…
20. 9. 2023 Source: Intestinal Inflammations
karcinom nosohltanu

Proton radiotherapy in patients with nasopharyngeal carcinoma increases chances of successful treatment

Nasopharyngeal carcinoma mainly affects younger people. It tends to be aggressive but responds very…
20. 9. 2023 Source: Proton Radiotherapy
roztroušená skleróza

Early Implementation of Highly Effective Therapy for Multiple Sclerosis

The ongoing debate about changing the approach to treating relapsing-remitting multiple sclerosis…
20. 9. 2023 Source: Neurology - Multiple Sclerosis
1 21 22 23 24 25 158
Filter by speciality
Remove filters

Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#